Assistive Technology Grants support researchers developing and adapting technologies that help people with ALS communicate, move, breathe, and manage daily activities to improve independence and quality of life.
Letters of intent are now marked closed, replacing the “now accepting applications” notice; the listed deadline was November 3, 2026, at 1 p.m. US EDT.
Seed Grants from the ALS Association support investigators conducting critical experiments to generate preliminary data for larger ALS research efforts aimed at treatments, cures, better care, or prevention.
Amyotrophic Lateral Sclerosis (ALS) 2027 supports New Jersey residents living with ALS and their families through clinical care and practical help at home to address care and daily mobility needs.
Funds assistive technology, adaptive equipment, and accessibility modifications to support people with disabilities moving from nursing facilities to independent living in Illinois.
The Hoffman ALS Clinical Trial Awards Program supports researchers conducting biomarker-driven early trials of ALS therapies and imaging tracers to advance treatment development and care.
ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.